Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22,163,711
-
Number of holders
-
72
-
Total 13F shares, excl. options
-
13,521,554
-
Shares change
-
+888,777
-
Total reported value, excl. options
-
$36,511,138
-
Value change
-
+$2,251,986
-
Number of buys
-
35
-
Number of sells
-
-35
-
Price
-
$2.70
Significant Holders of Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) as of Q1 2017
86 filings reported holding ADVM - Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share as of Q1 2017.
Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) has 72 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13,521,554 shares
of 22,163,711 outstanding shares and own 61% of the company stock.
Largest 10 shareholders include FMR LLC (2,770,550 shares), BlackRock Inc. (1,406,468 shares), RENAISSANCE TECHNOLOGIES LLC (1,141,977 shares), NUMERIC INVESTORS LLC (1,087,967 shares), EcoR1 Capital, LLC (874,447 shares), VANGUARD GROUP INC (630,302 shares), PRIMECAP MANAGEMENT CO/CA/ (440,400 shares), Casdin Capital, LLC (420,000 shares), 683 Capital Management, LLC (350,000 shares), and STATE STREET CORP (332,173 shares).
This table shows the top 72 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.